Because of the disruption caused by the Covid 19 pandemic, since 24 March 2020 the UK IPO has treated every day as an “interrupted day” as far as deadlines are concerned. This applies to UK applications and registrations for: patents, supplementary protection certificates, trade marks, designs. It also applies to deadlines in proceedings relating to these rights, such as oppositions and invalidity actions.
These past months have seen unprecedented global upheaval in view of the spread of the Coronavirus through Europe. Fortunately, the European Patent Office (EPO) and the UK Intellectual Property Office (UKIPO) have in place procedures to minimise the negative impacts on patent applicants and rights holders. We have been monitoring the situation closely and Pete Sadler provides the details.
rocery delivery service Ocado was forced to temporarily suspend parts of its online service last month due to coronavirus (Covid-19). The panic buying induced by the virus resulted in a tenfold increase demand. However, even before this unprecedented surge Ocado has been steadily growing over recent years. A quick Google search shows the impressive growth of Ocado’s share price since its initial public offering. Investment in technology and intellectual property (IP) have played a major role in this growth.
Do you have an innovative or novel approach to clean ambulances quicker to help combat COVID-19? The UK Government is asking for your help. Currently it can take up to 45 minutes to clean ambulances once they have transported a patient suspected of having COVID-19. Rapid sanitising technology solutions are required to enable ambulances to be effectively decontaminated faster, so that they can return to service as quickly as possible.
The COVID-19 pandemic has created a worldwide shortage of ventilators, and in the UK, the NHS is soon expected to require significantly more ventilators than are currently in circulation. As a result, on Monday 16th March, the UK government called for businesses to help make ventilators and ventilator components in an attempt to dramatically increase the number of ventilators available to the NHS in a matter of weeks. In response, both existing manufacturers of ventilators are increasing production and other manufacturing businesses are joining the effort.
At the time of writing, over one hundred and eighteen thousand cases of novel coronavirus (Covid-19) have been confirmed worldwide and this number is expected to rise significantly. In response to the outbreak, pharmaceutical companies and research organisations are racing to develop new vaccines and repurposing existing anti-viral drugs.